Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

ELITechGroup

Offers a range of products for in vitro diagnostics in clinical chemistry, hemostasis, microbiology, immunology, and ... read more Featured Products: More products

Download Mobile App





ELITechGroup Launches New SARS-CoV-2 PLUS ELITe MGB Kit

By LabMedica International staff writers
Posted on 17 Dec 2020
ELITech Group (Puteaux, France) has launched the CE-IVD marked SARS-CoV-2 PLUS ELITe MGB Kit that detects SARS-CoV-2, Flu A, Flu B, and RSV on the Sample-to Result-Platform ELITe InGenius and is available on major PCR thermocyclers as well.

The kit detects the RNA of the two genomic regions “ORF8 gene” and “ORF1ab gene” for SARS-CoV-2, the RNA of the genomic region “Influenza A Matrix Gene” for Flu A, the RNA of genomic region “Influenza B Matrix Gene” for Flu B, the RNA of Nucleoprotein gene sequence of Respiratory Syncytial Virus for hRSV, and a human RNAse P. More...
as an endogenous Internal Control to monitor the entire process from extraction to amplification.

The Kit is CE-IVD marked, allowing the possibility of carrying out 96 tests on the ELITe InGenius platform, the sample-to-result solution, capable of analyzing up to 12 samples simultaneously in two hours and 30 minutes, and of re-analyzing them for additional investigation without the need for further extraction of genetic material. SARS-CoV-2 PLUS ELITe MGB Kit is compatible with the main Real Time PCR Platforms to meet the requirements of all laboratories involved in the fight against SARS-CoV-2 and to distinguish it from the most relevant seasonal respiratory viral pathogens.




Gold Member
SARS-CoV-2 Reactive & Non-Reactive Controls
Qnostics SARS-CoV-2 Typing
Serological Pipet Controller
PIPETBOY GENIUS
New
Automated Microscope
dIFine
New
Drug Test Kit
DrugCheck 3000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
Image: Pancreatic cancer diagnosis (Photo courtesy of World Journal of Gastroenterology)

AI-Driven Preliminary Testing for Pancreatic Cancer Enhances Prognosis

Pancreatic cancer poses a major global health threat due to its high mortality rate, with 467,409 deaths and 510,992 new cases reported worldwide in 2022. Often referred to as the "king" of all cancers,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.